Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development. View Source Jaimy Lee MarketWatch.com – Top…
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development. View Source Jaimy Lee MarketWatch.com – Top…
Coal stocks advanced Wednesday following news that President Donald Trump plans to sign an executive order that could help the industry. View Source Victor Reklaitis…
Complacent high earners may be making tens of thousands of dollars less each year than they could be making elsewhere. View Source Venessa Wong MarketWatch.com…
Shopify executives say AI advancements are helping them attract and retain merchants. View Source Hannah Pedone MarketWatch.com – Top Stories February 11, 2026 8:30 am
View Source Most popular articles February 11, 2026 8:17 am
View Source Most popular articles February 11, 2026 8:12 am
Homeowners are behind on their mortgage payments in areas where unemployment rates are rising and home prices are dropping View Source Aarthi Swaminathan MarketWatch.com –…
CEO says Lyft will put more autonomous vehicles on the streets this year as it tries to keep up with Uber against a shaky ride-hailing…
Morgan Stanley strategists offer criteria on how to find the AI winners, saying the market is starting to demand proof of return on equity. View…
Since the pandemic and the war in Ukraine, governments have been increasingly conscious of energy and food supplies in particular. View Source Jules Rimmer MarketWatch.com…